Although GDPR is a law from the European Union, it affects healthcare groups around the world. It applies to any company that handles personal data of European people. Because healthcare systems are connected globally, medical practices in the United States that treat European patients or work with European partners must follow GDPR rules.
GDPR aims to protect personal data. It has strict rules about getting permission, being clear about data use, and only collecting data that is needed for a certain purpose. People have rights to see, fix, or delete their personal data. The law also says that AI systems should have privacy protections built in from the start, called “privacy by design.”
The French Data Protection Authority, called CNIL, gave recent advice about applying GDPR rules to AI systems. They said AI models, especially those using large data like healthcare records, need special data protection steps. These include:
For US healthcare groups, this means AI tools involving European data—or bought from European makers—must meet higher data protection standards. Following GDPR can also help US providers build trust with patients and use AI ethically across healthcare.
AI, especially types like generative AI and machine learning, works differently from regular software. It gives results that can be uncertain or hard to predict. This makes following data protection laws harder because those laws were made for simpler technology.
One problem is letting people exercise their rights to fix or delete data once it is inside an AI model. CNIL says AI models remember data in ways that can’t always be changed or removed. This means healthcare groups need special tools to honor patient requests under GDPR and similar laws like California’s CCPA.
Also, AI outputs could accidentally show private medical or biometric data if not made carefully, which is a privacy risk. Biometric data includes things like fingerprints, face scans, or voice patterns. This type of data cannot be changed and must be protected well to stop identity theft or misuse.
Hidden data collection methods like browser fingerprinting or tracking without consent can also break trust with patients and cause legal problems. These ways often avoid getting the proper permission, which GDPR requires.
US healthcare providers facing these issues must follow privacy by design rules—making data protection part of every step in AI development and use. This also includes checking AI for bias to prevent unfair treatment since biased AI can hurt patient healthcare access and quality.
Regulatory sandboxes are safe places where healthcare groups and AI makers can test new tech with some oversight but fewer legal penalties. The European Union requires sandboxes under its AI Act (2024). Countries like the US, France, Brazil, Kenya, Singapore, and Utah also use sandboxes to help innovation while keeping legal rules in mind.
Sandboxes help healthcare AI development in several ways in the US:
For example, Utah’s AI Lab looks at AI for mental health. Its use of sandbox exemptions helps makers improve tools while following rules.
European sandboxes, led by groups like CNIL, often focus on healthcare issues like eldercare, giving AI companies clear rules for GDPR compliance. Brazil’s sandbox includes input from schools and communities to make sure AI protects personal data and still advances technology.
US healthcare groups could gain by using sandbox ideas informally or working with global regulatory programs. This is useful if they work with European partners or want to grow internationally.
Healthcare data is very sensitive. Besides medical records, AI uses biometric data more often, which needs strong privacy protection.
Some big challenges are:
Healthcare groups are advised to:
Organizations like DataGuard Insights help healthcare providers with these tasks and getting security certificates, showing the need for expert help to handle AI safely.
One useful AI in healthcare is automating front-office phone calls and answering services. Companies like Simbo AI make AI tools to handle patient communication, lowering work for staff and speeding up replies.
For medical administrators and IT managers, this AI automation offers clear benefits:
The US healthcare field is using AI front-office automation more, especially as patient numbers grow and virtual care rises. This automation also helps meet privacy laws by safely handling personal data in both US and global settings.
Simbo AI’s tools follow this trend by making sure AI phone systems do not leak patient data during calls or storage. They use privacy by design ideas from regulators like CNIL. Their systems also offer consent choices that match US privacy laws like CCPA and GDPR when needed, helping providers work with patients worldwide.
Healthcare leaders who want to balance AI use and data protection under GDPR and US laws can try these steps:
AI in healthcare brings many benefits like better patient communication, easier workflows, and improved data use. But protecting personal data must stay a main concern. Strict laws like GDPR affect global healthcare, including the US. AI’s unpredictable nature and privacy risks mean healthcare groups need to build privacy in from the start, manage risks, and work with regulators using tools like sandboxes.
AI tools, especially for front-office communication, show how innovation and privacy can work together. They help US healthcare providers update technology while keeping patient information safe. Administrators, owners, and IT managers have a key role in guiding their groups to use AI properly, keeping trust and following rules as technology changes.
The GDPR provides a legal framework that balances innovation and personal data protection, enabling responsible AI use in healthcare while ensuring individuals’ fundamental rights are respected.
Key GDPR principles like data minimisation, purpose limitation, and individuals’ rights must be flexibly applied to AI contexts, considering challenges like large datasets and general-purpose AI systems.
Individuals must be informed about the use of their personal data in AI training, with the communication adapted to risks and operational constraints; general disclosures are acceptable when direct contact is not feasible.
Exercising rights such as access, correction, or deletion is difficult due to AI models’ complexity, anonymity, and data memorization, complicating individual identification and modification within models.
Data retention can be extended if justified and secured, especially for valuable datasets requiring significant investment and recognized standards, balancing utility and privacy risks.
Developers should incorporate privacy by design, aim to anonymise models without affecting their purpose, and create solutions preventing disclosure of confidential personal data by AI outputs.
Organizations may provide broad or general information, such as categories of data sources, especially when data comes from third parties and direct individual contact is impractical.
Refusal may be justified by excessive cost, technical impossibility, or practical difficulties, but flexible timelines and reasonable solutions are encouraged to respect individuals’ rights when possible.
CNIL’s recommendations are the result of broad consultations involving diverse stakeholders, ensuring alignment with real-world AI applications and fostering responsible innovation.
CNIL actively issues guidance, supports organizations, monitors European Commission initiatives like the AI Office, and coordinates efforts to clarify AI legal frameworks and good practice codes.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
